Response to Allopurinol and Febuxostat According to the Fractional Excretion of Urate in Men With Gout

Time-course of tophus resolution on Dual-energy CT and ultrasound after 24months of a treat-to-target strategy: Results from GOUT-DECTUS study

Addition of allopurinol to traditional Vietnamese medicine shows major improvement of 100 gout patients in a single center one-year prospective study

Hyperuricaemia and gout in the Pacific

The gout epidemic in French Polynesia: a modelling study of data from the Ma'i u'u epidemiological survey

Publisher Correction: A genome-wide association analysis reveals new pathogenic pathways in gout

A genome-wide association analysis reveals new pathogenic pathways in gout

Systemic inflammatory cytokine profiles in patients with gout during flare, intercritical and treat-to-target phases: TNFSF14 as new biomarker

Cardiovascular Safety of Febuxostat in Patients With Gout or Hyperuricemia: A Systematic Review of Randomized Controlled Trials

Early-onset gout and rare deficient variants of the lactate dehydrogenase D gene

Epidemiology of gout and hyperuricemia in New Caledonia

Uricaemia as a surrogate endpoint in gout trials and the treat-to-target approach for gout management

Simple Application and Adherence to Gout Guidelines Enables Disease Control: An Observational Study in French Referral Centres

The shrinking toe sign in gout

Calcium Pyrophosphate Dihydrate Crystal Deposition in Gouty Tophi

A cross-sectional study of 502 patients found a diffuse hyperechoic kidney medulla pattern in patients with severe gout

Development of a radiographic scoring system for new bone formation in gout

Distribution of bony erosions in feet and performance of two bone erosion scores: A dual-energy computed tomography study of 61 patients with gout

FAST: new look at the febuxostat safety profile

2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout

UltraSound evaluation in follow-up of urate-lowering therapy in gout phase 2 (USEFUL-2): Duration of flare prophylaxis

Answer to Checa « Coexistence of gout and chondrocalcinosis instead? », Joint Bone Spine 2020. doi:10.1016/j.jbspin.2020.07.007

Gout and pseudo-gout-related crystals promote GLUT1-mediated glycolysis that governs NLRP3 and interleukin-1β activation on macrophages

2020 Recommendations from the French Society of Rheumatology for the management of gout: Management of acute flares

2020 recommendations from the French Society of Rheumatology for the management of gout: Urate-lowering therapy

Can gout management guidelines be solely evidence based?

Risk factors for cutaneous reactions to allopurinol in Kinh Vietnamese: results from a case-control study

Ultrasound evaluation in follow-up of urate-lowering therapy in gout: the USEFUL study

Defining remission in patients with gout

Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout

The role of febuxostat in gout

Spermidine Reproduces the Anti-Inflammatory Effects of Intermittent Fasting and Prevents Urate and Calcium Pyrophosphate Crystal-Induced Inflammation

Diagnostic pathway for cardiac amyloidosis from the healthcare professional's perspective: results from the French DIAM-ATTR survey

Screening for transthyretin amyloid cardiomyopathy in patients with musculoskeletal symptoms: Red flags in the rheumatology/orthopedics practice setting

Features Associated With Different Inflammatory Phenotypes of Calcium Pyrophosphate Deposition Disease: A Study Using Data From the International American College of Rheumatology/EULAR Calcium Pyrophosphate Deposition Classification Criteria Cohort

The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease

The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease

Calcium pyrophosphate crystal deposition in a cohort of 57 patients with Gitelman syndrome

Eosinopenia to differentiate crystal-induced and septic arthritis

Identifying Potential Classification Criteria for Calcium Pyrophosphate Deposition Disease: Item Generation and Item Reduction

Shoulder adhesive capsulitis: diagnostic value of active and passive range of motion with volume of gleno-humeral capsule as a reference

Hyperuricemia and Hypertension, Coronary Artery Disease, Kidney Disease: From Concept to Practice

Chondrocalcinosis of the Knee and the Risk of Osteoarthritis Progression: Data From the Knee and Hip Osteoarthritis Long-term Assessment Cohort

Iterative percutaneous needle aponeurotomy for Dupuytren's disease: Functional outcome at 5-year follow-up

Monosodium urate deposition in the articular cartilage and meniscus can mimic chondrocalcinosis

Spinal involvement with calcium pyrophosphate deposition disease in an academic rheumatology center: A series of 37 patients

Evaluating the safety and short-term equivalence of colchicine versus prednisone in older patients with acute calcium pyrophosphate crystal arthritis (COLCHICORT): an open-label, multicentre, randomised trial

Do Glucocorticoid Injections Increase the Risk of Knee Osteoarthritis Progression Over 5 Years?

Evaluating the safety and short-term equivalence of colchicine versus prednisone in older patients with acute calcium pyrophosphate crystal arthritis (COLCHICORT): an open-label, multicentre, randomised trial

A single intra-articular injection of 2.0% non-chemically modified sodium hyaluronate vs 0.8% hylan G-F 20 in the treatment of symptomatic knee osteoarthritis: A 6-month, multicenter, randomized, controlled non-inferiority trial

Tocilizumab in symptomatic calcium pyrophosphate deposition disease: a pilot study

Evaluating the safety and short-term equivalence of colchicine versus prednisone in older patients with acute calcium pyrophosphate crystal arthritis (COLCHICORT): an open-label, multicentre, randomised trial